Navigation Links
Pravastatin Launched by Watson Pharmaceuticals

Pravastatin sodium has been launched by Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, under a distribution agreement with Bristol-Myers Squibb Company. Shipments of pravastatin sodium tablets// have been started by Watson, in the 10, 20 and 40 mg strengths.

Watson Pharmaceuticals, Inc. has its headquarters in Corona, CA. It is a leading specialty pharmaceutical company that specializes in the development, manufacture, marketing, and distribution of brand and generic pharmaceutical products. Watson owes its remarkable growth to the company’s strategy of combining internal product development along with strategic alliances and synergistic acquisitions of products and businesses.

This Pravastatin sodium is the authorized generic version of Bristol-Myers Squibb's Pravachol(R) product. It consumption has been recommended along with the diet to decrease risks of first heart attack in patients with cardiovascular risks such as elevated cholesterol. It has also been recommended to prevent recurrent heart attack or a stroke in patients with cardiovascular disease especially when diet and exercise are not enough to reverse the symptoms of the disease.

In the year 2005 Pravachol(R) produced sales of approximately $1.7 billion, according to IMS Health data.
'"/>




Page: 1

Related medicine news :

1. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
2. Nutrient Profiling System Launched By Food Officials in UK
3. New Oat And Soy-Based Fat Replacer Launched
4. Race Based Genome Project Launched By Mexico
5. Action Plan Against Drug Deaths Launched
6. New Fund Launched To Help HIV Positive Women
7. Use Of Viread Spreads As New Anti-AIDS Site Is Launched
8. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
9. Unique Smoking Helpline Launched In Manchester
10. Unique Smoking Helpline Launched In Manchester
11. New Home-Fertility Kit Launched For Men
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
(Date:4/21/2017)... ... 2017 , ... The VIA Agency , a full-service ... Theravent, Inc. , the makers of a revolutionary new device clinically proven to ... working to expand distribution in anticipation of a national launch. VIA will be ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 to ... and preventing substance use disorders. , The mission of AWARE is to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... the much anticipated Regional Primary Care Spring Symposium on April 1, 2017 in ... medical community, offering physicians and healthcare providers an opportunity to learn about cutting ...
(Date:4/21/2017)... ... , ... Providing for loved ones before one’s passing is of paramount importance. ... begin. “Now more than ever there are some questions that are far too critical ... said attorney Lisa Edgar Dickman, founder of the Law Offices of Lisa Edgar Dickman. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, Chile, ... their offering. ... Latin American pharmaceutical contract manufacturing services market is anticipated to ... registration cost in Latin American countries and continuous economic growth ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology: